Clinicopathological Characteristics of Patients with Gastric Cancer according to the Expression of LIN28A
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Although LIN28A is known to potentially play a role in the oncogenesis of various cancers, whether LIN28A expression is a predictor of poor prognosis in patients with gastric cancer has not been fully explored. We sought to evaluate clinicopathological characteristics according to the expression of LIN28A in numerous gastric cancer tissue samples. Methods: LIN28A expression was evaluated by immunohistochemical (IHC) analysis of a tissue microarray comprising 288 gastric cancer tissues and 288 adjacent normal tissues. Clinicopathological characteristics, including overall survival, were compared according to LIN28A expression. Results: The IHC staining score was lower for the cancer tissues than the normal tissues (p<0.001). However, no significant differences were observed in the clinicopathological characteristics between the low and high LIN28A expression groups. In addition, the 5-year overall survival rate did not differ between the two groups: 75.3% (95% confidence interval [CI], 69.3% to 81.7%) versus 71.6% (95% CI, 63.3% to 80.9%) for low versus high expression, respectively. Conclusions: The expression of LIN28A did not appear to play a distinct role in predicting the clinicopathological characteristics of patients with gastric cancer. In addition, LIN28A expression was not an independently associated factor for overall survival in patients with gastric cancer.
Abstract
Background/Aims: Although LIN28A is known to potentially play a role in the oncogenesis of various cancers, whether LIN28A expression is a predictor of poor prognosis in patients with gastric cancer has not been fully explored. We sought to evaluate clinicopathological characteristics according to the expression of LIN28A in numerous gastric cancer tissue samples. Methods: LIN28A expression was evaluated by immunohistochemical (IHC) analysis of a tissue microarray comprising 288 gastric cancer tissues and 288 adjacent normal tissues. Clinicopathological characteristics, including overall survival, were compared according to LIN28A expression. Results: The IHC staining score was lower for the cancer tissues than the normal tissues (p<0.001). However, no significant differences were observed in the clinicopathological characteristics between the low and high LIN28A expression groups. In addition, the 5-year overall survival rate did not differ between the two groups: 75.3% (95% confidence interval [CI], 69.3% to 81.7%) versus 71.6% (95% CI, 63.3% to 80.9%) for low versus high expression, respectively. Conclusions: The expression of LIN28A did not appear to play a distinct role in predicting the clinicopathological characteristics of patients with gastric cancer. In addition, LIN28A expression was not an independently associated factor for overall survival in patients with gastric cancer.
참고문헌 (30)
- Lee HJ, "Gastric cancer in Korea", Gastric Cancer, 5, pp.177~182 (2002)
- Isobe Y, "Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry", Gastric Cancer, 14, pp.301~316 (2011)
- Carter KJ, "Early gastric cancer", Ann Surg, 199, pp.604~609 (1984)
- Shimizu S, "Early gastric cancer: its surveillance and natural course", Endoscopy, 27, pp.27~31 (1995)
- Cunningham D, "Capecitabine and oxaliplatin for advanced esophagogastric cancer", N Engl J Med, 358, pp.36~46 (2008)
- Waddell T, "Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3):a randomised, open-label phase 3 trial", Lancet Oncol, 14, pp.481~489 (2013)
- Yang W, "Targeted therapy for gastric cancer:molecular pathways and ongoing investigations", Biochim Biophys Acta, 1846, pp.232~237 (2014)
- Moss EG, "The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA", Cell, 88, pp.637~646 (1997)
- Viswanathan SR, "Lin28 promotes transformation and is associated with advanced human malignancies", Nat Genet, 41, pp.843~848 (2009)
- Jain AK, "p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells", PLoS Biol, 10, pp.e1001268~ (2012)
- Lee JY, "Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells", Nucleic Acids Res, 41, pp.5614~5625 (2013)
- Nam Y, "Molecular basis for interaction of let-7 microRNAs with Lin28", Cell, 147, pp.1080~1091 (2011)
- Leung AK, "MicroRNA functions in stress responses", 40, pp.205~215 (2010)
- Newman MA, "Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing", RNA, 14, pp.1539~1549 (2008)
- Mao XG, "LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program", Oncotarget, 4, pp.1050~1064 (2013)
- Qiu C, "Lin28-mediated posttranscriptional regulation of Oct4 expression in human embryonic stem cells", Nucleic Acids Res, 38, pp.1240~1248 (2010)
- Yu J, "Induced pluripotent stem cell lines derived from human somatic cells", Science, 318, pp.1917~1920 (2007)
- Lv K, "Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells", PLoS One, 7, pp.e40008~ (2012)
- Peng S, "Pluripotency factors Lin28 and Oct4identify a sub-population of stem cell-like cells in ovarian cancer", Oncogene, 29, pp.2153~2159 (2010)
- Saiki Y, "Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells", Ann Surg Oncol, 16, pp.2638~2644 (2009)
- Xu C, "Positive expression of Lin28 is correlated with poor survival in gastric carcinoma", Med Oncol, 30, pp.382~ (2013)
- Rimm DL, "Tissue microarray: a new technology for amplification of tissue resources", Cancer J, 7, pp.24~31 (2001)
- Balzer E, "LIN28 alters cell fate succession and acts independently of the let-7 microRNA during neurogliogenesis in vitro", Development, 137, pp.891~900 (2010)
- Zhu H, "The Lin28", let-7 axis regulates glucose metabolism, 2011, pp.147, 81~94
- Shyh-Chang N, "Lin28 enhances tissue repair by reprogramming cellular metabolism", Cell, 155, pp.778~792 (2013)
- Cho J, "LIN28A is a suppressor of ERassociated translation in embryonic stem cells", Cell, 151, pp.765~777 (2012)
- Das K, "Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH", Cancer Lett, 353, pp.167~175 (2014)
- Nishida Y, "A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity", Gastric Cancer, 18, pp.458~466 (2015)
- Wang T, "Aberrant regulation of the LIN28A", LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer, 2015, pp.14, 125~
- Piskounova E, "Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms", Cell, 147, pp.1066~1079 (2011)